Key points are not available for this paper at this time.
Strategic plans need to be evaluated in rational economic terms. Earnings per share and book ROI no longer do the job. What is needed, the author contends, is a new shareholder value approach.
Alfred Rappaport (Tue,) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: